Navigation Links
Christine Poon Will Keynote MichBio Expo
Date:6/25/2008

ANN ARBOR, Mich., June 25 /PRNewswire/ -- MichBio announced that Johnson & Johnson Vice Chairman, Christine A. Poon will be the keynote speaker for its statewide Expo and Conference November 18-19 in Novi, Michigan. MichBio is the association for Michigan's life science industry, and its annual Expo is the state's premier life science event attracting more than 450 attendees and 60 exhibitors last year.

"Christine is one of the most respected professionals in the industry, and we are absolutely thrilled to be able to bring her to Michigan for the MichBio Expo," said Stephen Rapundalo, Ph.D., MichBio Executive Director. "At a time when the vision for Michigan's life sciences industry is coming into better focus, and we are recognizing what we need to capitalize on our strengths and successes, it will be interesting and illuminating to have the benefit of Christine's global perspective and experienced viewpoint."

Johnson & Johnson is a 122 year-old multinational conglomerate that continues with leadership positions in consumer health products, pharmaceuticals, medical devices and biologics. Ms. Poon joined Johnson & Johnson in 2000 as Group Chairman in the Pharmaceuticals Group. She was named Worldwide Chairman, Medicines & Nutritionals in 2003 and was appointed Vice Chairman in 2005. In January of this year, she was named Worldwide Chairman of the Pharmaceuticals Group. She is responsible for managing the pharmaceutical, consumer pharmaceutical and nutritional businesses of the company, in addition to overseeing its expanding R&D pipeline. She is also a member of the company's Executive Committee.

Prior to joining Johnson & Johnson, Ms. Poon served in various management positions at Bristol-Myers Squibb Company for 15 years, most recently as President of International Medicines (1998-2000) and President of Medical Devices (1997-1998). She is a Director of Prudential Financial Inc., the US-China Business Council, and the Fox Chase Cancer Ce
'/>"/>

SOURCE MichBio
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Innovative and Forward-Thinking Experts to Deliver Keynote Presentations at IBCs 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress
2. Merck & Co., Inc. Named Keynote Sponsor For Diversity Alliance For Sciences Inaugural Conference
3. National Stem Cell Holding, Inc. to Present Keynote Address at The Stem Cell Partnering Series Inaugural Meeting in San Diego
4. MichBio Announces Annual Meeting Keynote and Pre-Meeting Workshop
5. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
6. Epeius Biotechnologies Leads With Keynote Address on the Advent of Pathotropic Medicine for Cancer at the Global Pharma R&D Summit Conference in Boston MA
7. MHA Announces: Tommy Thompson to be Keynote Speaker at The MHA 5th Annual Business Summit
8. AGI Dermatics President to be Keynote Speaker at the 11th Annual Sunscreen Symposium
9. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
10. MichBio Responds to Governors Plan to Repeal Tort Reform Laws
11. MichBio Expo Opens in Lansing Next Week

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...swire-FirstCall/ -- ,, 3Q09 Corporate Highli....U. Marketing Authorization to Astellas Pharma Eur... readiness activities Expanded management team to... Director, Commercial Operations Appointed Bradfo...ttee chairman , Upcoming 2009 Milestones: ...
(Date:11/6/2009)...tCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:...ced updated results from a Phase II study of intra...tatic to the lung in a poster presentation at the ...ting held in Miami Beach, Florida, from November 5...ase II Study of Intravenous REOLYSIN (Wild-type Re...
(Date:11/6/2009)...or Arrowhead’s 2010 Personalized Medicine Pa...on February 22-24, 2010 in Philadelphia, has been ...ghlight key issues in forming partnerships and eng... , Minneapolis, MN (PRWEB)...o;s 2010 Personalized Medicine Partnerships Confe...
(Date:11/5/2009)...swire-FirstCall/ -- GenVec, Inc. (Nasdaq: GNVC ) ...d quarter ended September 30, 2009. GenVec reporte... the three months ended September 30, 2009 compare...in the comparable quarter of 2008. For the nine mo...as $14.1 million ($0.15 per share), compared to a ...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... April 20 Santaris Pharma announced today,promisi...f microRNA-targeted,therapeutics against cancer de...leic Acid (LNA) Drug Platform. In both in vitro an... LNA-antimiR(R),s demonstrated outstanding,recogni...s due to their high,specificity and affinity. The ...
...nowned Physicians Join World Class Group of Adviso...nc. today announced the expansion of its Clinical ...FIDSA, and G. Ralph Corey, MD, as the sixth and se...ht leaders. Dr. Batts is a Professor of Medicine ...fectious Diseases at its Kalamazoo Campus. Dr. Co...
...ublication in Nature Photonics , a joint team of ...l Physics Center DIPC, Centro de Fsica de Material...rd University (USA) and the Max Planck Institute o...vative method for controlling light on the nanosca...y technology. The method opens the door for target...
Other Biology Technology:LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs 2Trius Appoints Don Batts and Ralph Corey to Clinical Advisory Board 2Bridging the gap in nanoantennas 2Bridging the gap in nanoantennas 3
(Date:11/4/2009)... received more than $10 million in research grants... stimulus program, bringing thetotal amount of sti...llion. Thirty-three projects achieved stimulus fu...her. , "The university has thoughtfully undertak...arly excellence to federal agency priorities. Thr...
(Date:11/4/2009)...FirstCall/ -- Aware, Inc. (Nasdaq: AWRE ), a lead...s software, today reported financial results for i..., Michael Tzannes, Aware,s Chairman and Chief Exec...an agreement to sell our DSL and home networking p...r company being spun out of Infineon. This transa...
(Date:11/4/2009)...obal Rainmakers, Inc., an intellectual property ho...ay announced that the company has exited its "stea...e its suite of technologies designed to leverage c...ring the past four years, the company has spent te...series of core--but expandable--technologies built...
Breaking Biology News(10 mins):OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 2OU achieves $10 million in stimulus grants for 33 projects on the Norman campus 3Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3National League of Cities Commends President and Congress on Work Towards Health Care Reform 53390 1National League of Cities Commends President and Congress on Work Towards Health Care Reform 53390 2Blood Transfusions Not Linked to Long Term Problems 53386 1NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 1NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 2NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 3NFL Cardinals Wide Receiver Larry Fitzgerald Promotes Vision Therapy 53382 4
...utant mouse that is highly susceptible to mammary ...ential link between genetic defects in DNA replica...ains a mutation in a gene essential for replicatin...ate of flawed copies of genetic material, leading ...in Nature Genetics online (and upcoming in the Dec...
...d analysis of fifty years of remotely sensed image...on in the size and number of more than 10,000 pond... Fairbanks scientists and published this week in t... these landscape-level changes in arctic ponds are...and may have profound effects on climate and wildl...
...ly overweight people -- consume up to 50 percent m...ck foods than when they eat the regular versions, ...panion study finds, when food labels show serving ...r chocolates, normal-weight people tend not to ove... a world of fat-free, carb-free and sugar-free pro...
Other Biology News:Mutant mouse provides insights into breast cancer 2Shrinking ponds signal warmer, dryer Alaska 2
ELISA Strips from Santa Cruz Biotechnology, Inc.
...ides offers multiple drive technologies including ...d manual. With this series, users can construct hi... These slides also offer anti-cage creep cross-rol...eters, integrated home/ limit switches, and high-f...
EGTA, Molecular Biology Grade from Research Organics, Inc.
EGTA, Molecular Biology Grade from Research Organics, Inc.
Biology Products: